General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0HQVXQ
ADC Name
TORL-3-600
Synonyms
TORL-3-600; TORL-3-600 ADC; TORL-3-600-ADC
   Click to Show/Hide
Organization
TORL Biotherapeutics LLC; Translational Research In Oncology US, Inc.
Drug Status
Phase 1
Indication
In total 1 Indication(s)
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
Undisclosed
Antibody Name
Undisclosed
Antigen Name
Cadherin-17 (CDH17)
 Antigen Info 
Payload Name
Monomethyl auristatin E
 Payload Info 
Therapeutic Target
Microtubule (MT)
 Target Info 
Linker Name
Undisclosed
Conjugate Type
Undisclosed